US Centers for Medicare & Medicaid Services payment changes for new oxygen technology & creates new category
This article was originally published in Clinica
Certain new devices that eliminate the need to deliver oxygen to a patient's home may qualify for higher Medicare payments under a US proposal released on July 27 by the Centers for Medicare & Medicaid Services.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.